15.80Open15.80Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover483.62%IV-11.05%PremiumDec 20, 2024Expiry Date17.71Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7933Delta0.0265Gamma0.93Leverage Ratio-0.2473Theta-0.0045Rho-0.74Eff Leverage0.0064Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet